Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
PPARD Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | Q03181 |
|---|---|
| Clone Names | 100430077 |
| Gene ID | 5467 |
|---|---|
| Other Names | Peroxisome proliferator-activated receptor delta, PPAR-delta, NUCI, Nuclear hormone receptor 1, NUC1, Nuclear receptor subfamily 1 group C member 2, Peroxisome proliferator-activated receptor beta, PPAR-beta, PPARD, NR1C2, PPARB |
| Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13778b was selected from the C-term region of PPARD. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | PPARD (HGNC:9235) |
|---|---|
| Synonyms | NR1C2, PPARB |
| Function | Ligand-activated transcription factor key mediator of energy metabolism in adipose tissues (PubMed:35675826). Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma- linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand. |
| Cellular Location | Nucleus. |
| Tissue Location | Ubiquitous with maximal levels in placenta and skeletal muscle |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a member of the peroxisomeproliferator-activated receptor (PPAR) family. PPARs are nuclearhormone receptors that bind peroxisome proliferators and controlthe size and number of peroxisomes produced by cells. PPARs mediatea variety of biological processes, and may be involved in thedevelopment of several chronic diseases, including diabetes,obesity, atherosclerosis, and cancer. This protein is a potentinhibitor of ligand-induced transcription activity of PPAR alphaand PPAR gamma. It may function as an integrator of transcriptionrepression and nuclear receptor signaling. The expression of thisgene is found to be elevated in colorectal cancer cells. Theelevated expression can be repressed by adenomatosis polyposis coli(APC), a tumor suppressor protein related to APC/beta-cateninsignaling pathway. Knockout studies in mice suggested the role ofthis protein in myelination of the corpus callosum, lipidmetabolism, and epidermal cell proliferation. Alternate splicingresults in multiple transcript variants.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Christopoulos, P., et al. Ann. N. Y. Acad. Sci. 1205, 185-191 (2010) :Dunn, S.E., et al. J. Exp. Med. 207(8):1599-1608(2010)Eynon, N., et al. Mitochondrion (2010) In press :Jguirim-Souissi, I., et al. Genet. Mol. Res. 9(3):1326-1333(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
